This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Concord Medical's CEO Discusses Second Quarter Results - Earnings Call Transcript

Concord Medical (CCM)

Q2 2012 Earnings Call

August 21, 2012, 08:00 am ET

Executives

Tony Tian – Investor Relations Manager

Jianyu Yang – Chairman, CEO

Adam Sun – CFO

Analysts

Isabella Hau – Morgan Stanley

Sean Wu – JPMorgan

(Mital Kraus) – Private Investor

Presentation

Operator

Hello and thank you for standing by the Concord Medical second quarter 2012 earnings conference call. At this time, all participants are in listen-only mode. After management's prepared remarks, there will be a question-and-answer session. Today's conference is being recorded. If you have any objections, you may disconnect at this time.

I would now like to turn the meeting over to your host for today's conference, Tony Tian, Investor Relations Manager of Concord Medical. Mr. Tian, you may begin.

Tony Tian

Thanks. Hello, everyone, and welcome to Concord Medical's secdon quarter 2012 earnings conference call. Concord Medical's earnings release was distributed earlier today and you can find a copy on our website as well as on News Wire Services.

Today, you will hear from Dr. Jianyu Yang, Concord Medical's Chairman and CEO, and Mr. Adam Sun, Chief Financial Officer.

After their prepared remarks, Jianyu Yang and Mr. Sun will be available to answer your questions. Before we continue, please note that the discussion today will contain forward-looking statements made under the Safe Harbor provisions of the US Private Securities Litigation Reform Act of 1995 and within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended.

Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from our current expectations. Potential risks and uncertainties include but are not limited to t hose outlined in our public findings with the SEC.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,089.62 +65.56 0.36%
S&P 500 2,117.88 +9.59 0.45%
NASDAQ 5,032.9770 +27.5860 0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs